Literature DB >> 32892549

The role and importance of auxiliary tests in differential diagnosis in patients with mildly high basal 17-OH-progesterone levels in the evaluation of hirsutism

Taner Demirci1, Hasret Cengiz1, Ceyhun Varım2, Sedat Çetin1.   

Abstract

Background/aim: In the differential diagnosis of hirsutism, early follicular basal 17-OH-progesterone levels sometimes overlap with the diagnosis of late onset congenital adrenal hyperplasia (LOCAH) and other causes of hyperandrogenism. This study aims to investigate the role of some common tests and clinical findings in differential diagnosis in such cases. Materials and methods: One hundred seventy-five female patients with hirsutism and mildly high initial 17-OH-progesterone levels (2-10 ng/mL) were included in the study. The cases were divided into three groups according to their diagnosis: LOCAH (n = 16, mean age = 26.1 ± 6.9), polycystic ovary syndrome (PCOS) (n = 122, mean age = 23.9 ± 5.1), and intracranial hypertension (IH) (n = 37, mean age = 25.2 ± 7.3). Clinical signs and symptoms, such as menstrual irregularity and hirsutism score, and hormone levels including total testosterone and dehydroepiandrosterone sulfate (DHEAS), were compared between the groups.
Results: There was no difference between the groups with PCOS, LOCAH, and IH for total testosterone level results (P = 0.461). The DHEAS level was higher in the PCOS group than in the LOCAH group (449.6 ± 151.14 vs. 360.31 ± 152.40, P = 0.044). While there was no difference between the PCOS and LOCAH groups in terms of menstrual irregularity (P = 0.316), the hirsutism score for IH was significantly lower than those of PCOS and LOCAH (9.2 vs. 12.2 and 11.1, respectively; P < 0.001). Basal 17-OH-progesterone levels were higher in the LOCAH group than in the other groups (P = 0.016).
Conclusion: While DHEAS level was lower in LOCAH than in PCOS, it was not different from that in IH. While the severity of hirsutism was higher in LOCAH than in IH, it was not different from that in PCOS. Menstrual irregularity was similar between PCOS and LOCAH. According to these results, although the auxiliary tests and clinical findings for the diagnosis of LOCAH contribute to the clinical interpretation, they are not superior to the 17-OH-progesterone level for diagnosis. This work is licensed under a Creative Commons Attribution 4.0 International Licens

Entities:  

Keywords:  Late-onset congenital adrenal hyperplasia (LOCAH); polycystic ovary syndrome (PCOS); 17-OH-progesterone; dehydroepiandrosterone sulphate (DHEAS); idiopathic hyperandrogenism (IH)

Year:  2020        PMID: 32892549      PMCID: PMC7775709          DOI: 10.3906/sag-2004-263

Source DB:  PubMed          Journal:  Turk J Med Sci        ISSN: 1300-0144            Impact factor:   0.973


  24 in total

Review 1.  Congenital adrenal hyperplasia.

Authors:  Phyllis W Speiser; Perrin C White
Journal:  N Engl J Med       Date:  2003-08-21       Impact factor: 91.245

Review 2.  Clinical practice. Hirsutism.

Authors:  Robert L Rosenfield
Journal:  N Engl J Med       Date:  2005-12-15       Impact factor: 91.245

3.  Clinical and psychological correlates of quality-of-life in polycystic ovary syndrome.

Authors:  Susanne Hahn; Onno E Janssen; Susanne Tan; Katja Pleger; Klaus Mann; Manfred Schedlowski; Rainer Kimmig; Sven Benson; Efthimia Balamitsa; Sigrid Elsenbruch
Journal:  Eur J Endocrinol       Date:  2005-12       Impact factor: 6.664

4.  High frequency of nonclassical steroid 21-hydroxylase deficiency.

Authors:  P W Speiser; B Dupont; P Rubinstein; A Piazza; A Kastelan; M I New
Journal:  Am J Hum Genet       Date:  1985-07       Impact factor: 11.025

5.  Women living with facial hair: the psychological and behavioral burden.

Authors:  Michelle G Lipton; Lorraine Sherr; Jonathan Elford; Malcolm H A Rustin; William J Clayton
Journal:  J Psychosom Res       Date:  2006-08       Impact factor: 3.006

Review 6.  Disorders of the aldosterone synthase and steroid 11beta-hydroxylase deficiencies.

Authors:  M Peter; J M Dubuis; W G Sippell
Journal:  Horm Res       Date:  1999

Review 7.  Congenital adrenal hyperplasia due to 21-hydroxylase deficiency.

Authors:  P C White; P W Speiser
Journal:  Endocr Rev       Date:  2000-06       Impact factor: 19.871

Review 8.  Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS).

Authors: 
Journal:  Hum Reprod       Date:  2004-01       Impact factor: 6.918

9.  The prevalence of late onset congenital adrenal hyperplasia in hirsute women from Central Anatolia.

Authors:  Nuri Kamel; Vedia Tonyukuk; Rifat Emral; Demet Corapçioğlu; Mehmet Baştemir; Sevim Güllü
Journal:  Endocr J       Date:  2003-12       Impact factor: 2.349

10.  Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline.

Authors:  Richard S Legro; Silva A Arslanian; David A Ehrmann; Kathleen M Hoeger; M Hassan Murad; Renato Pasquali; Corrine K Welt
Journal:  J Clin Endocrinol Metab       Date:  2013-10-22       Impact factor: 5.958

View more
  1 in total

Review 1.  Criteria for Diagnosis of Polycystic Ovary Syndrome during Adolescence: Literature Review.

Authors:  Alexia S Peña; Ethel Codner; Selma Witchel
Journal:  Diagnostics (Basel)       Date:  2022-08-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.